Extended trial tests new transplant drug against standard treatment
Disease control
ENROLLING_BY_INVITATION
This study follows kidney transplant patients for up to four years to compare the long-term safety and effectiveness of an experimental drug called tegoprubart against the standard medication tacrolimus. The goal is to see which treatment better prevents organ rejection while cau…
Phase: PHASE2 • Sponsor: Eledon Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC